Myocardial angiogenesis as a possible mechanism for TMLR efficacy

Journal of Clinical Laser Medicine and Surgery

Volumn 15, Issue 6, 1997, Pages 275-279

  Mack, Charles A ^a   Patel, Shailen R ^a   Rosengart, Todd K ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; BLOOD VESSELS; CARDIOVASCULAR SURGERY; LASER TISSUE INTERACTION;

ANGIOGENESIS; TRANSMYOCARDIAL LASER REVASCULARIZATION;

LASER SURGERY;

BINDING PROTEIN; MESSENGER RNA; VASCULOTROPIN;

ANGINA PECTORIS; ANGIOGENESIS; ARTICLE; CORONARY ARTERY DISEASE; GENE EXPRESSION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; ISCHEMIC HEART DISEASE; LASER; SYMPTOMATOLOGY;

EID: 0031469720     PISSN: 10445471     EISSN: None     Source Type: Journal    
DOI: 10.1089/clm.1997.15.275     Document Type: Article

References (64)

1. Mirhoseini, M., and Cayton, M. (1981). Revascularization of the heart by laser. J. Microsurg. 2, 253-260.
2. Okada, M., Shimizu, K., Ikuta, H., Horii, H., and Nakamura, K. (1992). A new method of myocardial revascularization by laser. J. Thorac. Cardiovasc. Surg. 39, 1-4.
3. Frazier, O.H., Cooley, D.A., Kadipasaoglu, K.A., et al. (1995). Myocardial revascularization with laser. Preliminary findings. Circulation 92(Suppl. 2), II 58-65.
4. Cooley, D.A., Frazier, O.H., Kadipasaoglu, K.A., et al. (1996). Transmyocardial laser revascularization: Clinical experience with twelve-month follow-up. J. Thorac. Cardiovasc. Surg. 111, 791-797.
5. Horvath, K.A., Cohn, L.H., Cooley, D.A., et al. (1997). Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J. Thorac. Cardiovasc. Surg. 113, 645-653.
6. Zlotnick, A.Y., Ahmad, R.M., Reul, R.M., Laurence, R.G., Aretz, H.T., and Cohn, L.H. (1996). Neovascularization occurs at the site of closed laser channels after transmyocardial laser revascularization. Surg. Forum 47, 286-287.
7. 2 and Holmium:YAG lasers. Ann. Thorac. Surg. 64, 466-472.
8. Mack, CA., Magovem, C.J., Hahn, R.T., et al. (1997). Channel patency and neovascularization following transmyocardial revascularization utilizing an excimer laser: Results and comparisons to non-lased channels. Circulation (In press).
9. Gilbert, S.F. (1991). Developmental Biology. 3rd ed. Sunderland, MA: Sinauer Associates, pp. 891.
10. Folkman, J., and Klagsbrun, M. (1987). A family of angiogenic peptides. Nature. 329, 671-672.
11. Folkman, J., and Haudenschild, C. (1980). Angiogenesis in vitro. Nature. 288, 551-556.
12. Schaper, W., and Ito, W. (1996). Molecular mechanisms of coronary collateral vessel growth. Circ. Res. 79, 911-919.
13. Asahara, T., Murohara, T., Sullivan, A., et al. (1997). Isolation of putative progenitor endothelial cells for angiogenssis. Science 275, 964-967.
14. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med. 1, 27-31.
15. Folkman, J. and Shing, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
16. Klagsbrun, M., and Folkman, J. (1990). Angiogenesis. In: Sporn, M.B., and Roberts, A.B. (eds) Peptide Growth Factors and Their Receptors II. Berlin, Heidelberg and New York: Springer-Verlag, pp. 549-574.
17. Montesano, R. (1992). Mack Forster Award Lecture. Review. Regulation of angiogenesis in vitro. Eur. J. Clin. Invest. 22, 504-515.
18. Risau, W. (1990). Angiogenic growth factors. Prog. Growth Factor Res. 2, 71-79.
19. Weinstat-Saslow, D., and Steeg, P.S. (1994). Angiogenesis and colonization in tumor metastatic process: Basic and applied advances. FASEB J. 8, 401-407.
20. Folkman, J., Merler, E., Abernathy, C., and Williams, G. (1971). Isolation of a tumor factor responsible for angiogenesis. J. Exp. Med. 133, 275-288.
21. Gospodarowicz, D., Ferrara, N., Schweigerer, L., and Neufeld, G. (1987). Structural characterization and biologic functions of fibroblast growth factor. Endocrine Rev. 8, 95-114.
22. Burgess, W.H., and Maciag, T. (1989). The heparin-binding (fibroblast) growth factor family of proteins. Ann. Rev. Biochem. 58, 575-606.
23. Brindle, N.P.J. (1993). Growth factors in endothelial regeneration. Cardiovasc. Res. 27, 1162-1172.
24. Baird, A., and Bohlen, P. (1990). Fibroblast Growth Factors. In: Sporn, M.B., and Roberts, A.D. (eds) Peptide Growth Factors and Their Receptors I. Berlin Heidelberg New York: Springer-Verlag, pp. 369-418.
25. Houssaint, E., Blanquet, P., Champion-Araoud, P., et al. Related fibroblast growth factor receptor genes exist in the human genome. Proc. Natl. Acad. Sci. USA 87, 8180-8184.
26. Johnson, D., Lee, P., Lu, J., and Williams, L. (1990). Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol. Cell. Biol. 10, 4728-4736.
27. Moscatelli, D. (1988). Metabolism of receptor-bound and matrix-bound basic fibroblast growth by bovine capillary endothelial cells. J. Cell. Biol. 107, 753-759.
28. Yayon, A., Klagsbrun, M., Esko, J., Leder, P., and Ornitz, D. (1991). Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64, 841-848.
29. Brown, K.J., Hendry, I.A., and Parish, C.R. (1995). Acidic and basic fibroblast growth factors bind with differing affinity to the same heparain sulfate proteoglycan on BALB/c 3T3 cells: Implications for potentiation of growth factor action by heparin. J. Cell. Biochem. 58, 6-14.
30. Reich-Slotky, R., Bonneh-Barkay, D., Shaoul, E., Bluma, B., Svahn, C.M., and Ron, D. (1994). Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor. J. Biol. Chem. 269, 32279-32285.
31. Houck, K.A., Leung, D.W., Rowland, A.M., Winer, J., and Ferrara, N. (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26031-26037.
32. Gospodarowicz, D., Abraham, J., and Schilling, J. (1989). Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. USA 86, 7311-7315.
33. Ferrara, N., and Henzel, W.J. (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161, 851-858.
34. Ferrara, N., Houck, K., Jakeman, L., Winer, J., and Leung, D. (1991). The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47, 211-218.
35. Shibuya, M., Yamaguchi, S., Yamane, A., et al. (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5, 519-524.
36. Terman, B., Dougher-Vermazen, M., Carrion, M., et al. (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 187, 1579-1586.
37. Neufeld, G., Tessler, S., Gitay-Goren, H., Cohen, T., and Levi, B-Z. (1994). Vascular endothelial growth factor and its receptors. Prog. Growth Factor Res. 5, 89-97.
38. Leung, D., Cachianes, G., Kuang, W.-J., Goeddel, D., and Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
39. Houck, K.A., Ferrara, N., Winer, J., Cachianes, G., Li, B., and Leung, D.W. (1991). The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5, 1806-1814.
40. Tischer, E., Mitchell, R., Hartman, T., et al. (1991). The Human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954.
41. Park, J., Keller, G.A., and Ferrara, N. (1993). The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Chem. 4, 1317-1326.
42. Takeshita, S., Yukio, T., Thierry, C., et al. (1996). Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75, 487-501.
43. Liotta, L.A., Steeg, P.S., and Stetler-Stevenson, W.G. (1991). Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64, 327-336.
44. Folkman, J. (1987). 11th Congress of Thrombosis and Haemostasis. Verstraete, M. et al. (eds) Leuven: Leuven University Press pp. 583-596.
45. Banai, S., Shweiki, D., Pinson, A., Chandra, M., Lazarovici, G., and Keshet, E. (1994). Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis. Cardiovasc. Res. 28, 1176-1179.
46. Li, J., Brown, L., Hibberd, M., Grossman, J., Morgan, J., and Simons, M. (1996). VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol. 270 (Heart Physiol. 39) H1803-H1811.
47. Ikeda, E, Achen, M.G., Breier, G., and Risau, W. (1995). Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270, 19761-19766.
48. Kuwabara, K., Ogawa, S., Matsumoto, M., et al. (1995). Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Natl. Acad. Sci. USA 92, 4606-4610.
49. Rosengart, T., Duenas, M., Winkles, J., Krieger, K., and Isom, O.W. (1994). Ischemia is associated with increased expression of the angiogenic protein acidic fibroblast growth factor: Implications for "biologic" revascularization. Surg. Forum 45, 392-395.
50. Gajdusek, C.M., and Carbon, S. (1989). Injury induced release of basic fibroblast growth factor from bovine aortic endothelial cells. J. Cell. Physiol. 139, 570-579.
51. Saksela, O., and Rifkin, D.B. (1990). Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell. Biol. 110, 767-775.
52. Ishai-Michaeli, R., Eldor, A., and Vlodavsky, I. (1990). Heparanase activity expressed by platelets, neutrophils and lymphoma cells releases active fibroblast growth factor from extracelluar matrix. Cell. Regul. 1, 833-842.
53. Klagsbrun, M., and D'Amore, P.A. (1991). Regulators of angiogenesis. Annu. Rev. Physiol. 53, 217-239.
54. O'Reilly, M.A., Holmgren, L., Shing, Y., et al. (1994). Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
55. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
56. Hashimoto, E., Ogita, T., Nakaoka, T., Matsuoka, R., Takao, A., and Kira, Y. (1994). Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am. J. Physiol. 267 (Heart Circ. Physiol. 36), H1948-H1954.
57. Yanagisawa-Miwa, A., Uchida, Y., Nakamura, F., et al. (1992). Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257, 1401-1403.
58. Sellke, F., Li, J., Stamler, A., Lopez, J., Thomas, K., and Simons, M. (1996). Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery 120, 182-188.
59. Harada, K., Grossman, W., Friedman, M., et al. (1994). Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Invest. 94, 623-630.
60. Lazarous, D.E., Scheinowitz, M., Shou, M., et al. (1995). Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91, 145-153.
61. Banai, S., Jaklitsch, M.T., Shou, M., et al. (1994). Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183-2188.
62. Pearlman, J.D., Hibberd, M.G., Chuang, M.L., et al. (1995). Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. 1, 1085-1089.
63. Giordano, F.J., Ping, P., McKirnan, M.D., et al. (1996). Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of heart. Nat. Med. 2, 534-539.
64. 121 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg. 115 (in press).